Cellular mechanisms involved in the breakdown of articular cartilage

Autor: Jubb, R. W.

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.344617

Field Studies of Six Southern African Species of Erythrina

Autor: Guillarmod, A. Jacot, Jubb, R. A., Skead, C. J.

Publikováno v: Annals of the Missouri Botanical Garden, 1979 Jan 01. 66(3), 521-527.

Externí odkaz: https://www.jstor.org/stable/2398844

Inner ear deafness in Wegener's granulomatosis

Autor: Raashid Luqmani, Jubb, R., Emery, P., Reid, A., Adu, D.

Publikováno v: Scopus-Elsevier

Autoimmune deafness represents a heterogeneous group of disorders in which there is though to be inner ear and/or middle ear damage mediated by various immunological abnormalities. We describe a patient with Wegener's granulomatosis in whom there was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ccfd658a985bd4401094f53a0962327e
https://ora.ox.ac.uk/objects/uuid:5100d703-caf9-45cf-806a-7d8676783366

Why moralists should be afraid of political values

Autor: Jubb, R., Rossi, E.

Publikováno v: Journal of Philosophical Research, 40, 465-468. Philosophy Documentation Center

In this rejoinder to Erman and Möller’s reply to our "Political Norms and Moral Values," we clarify the sense in which there can be specifically political values, and expound the practice-dependent notion of legitimacy adopted by our preferred ver

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0443c6104ad88f1fc9e761852c917047
https://dare.uva.nl/personal/pure/en/publications/why-moralists-should-be-afraid-of-political-values(cf932422-cda9-473a-9c9c-b67c0631725f).html

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

Autor: Rubbert Roth, Andrea, Tak, Paul P, Zerbini, Cristiano, Tremblay, Jean Luc, Carreño, Luis, Armstrong, Gillian, Collinson, Neil, Shaw, Tim M, MIRROR Trial Investigators, Nash, P, Bagga, H, Hall, S, Littlejohn, G, Manolios, N, Van Den Bosch, F, Ximenes, Ac, Mccarthy, T, Atkins, C, Thorne, Jc, Offer, R, Pope, J, Keystone, E, Huang, F, Wu, D, Karjalainen, A, Schaeverbeke, T, Euller Ziegler, L, Jorgensen, C, Nguyen, M, Puechal, X, Wassenberg, S, Heilig, B, Mueller Ladner, U, Wollenhaupt, J, Braun, J, Gauler, G, Szekanecz, Z, Nagy, K, Galeazzi, M, Trotta, F, Bombardieri, S, Salvarani, Carlo, Pellerito, R, Seriolo, B, Adami, S, Bianchi, G, Giacomelli, R, Arioli, G, Cantini, F, Ching, D, Gilchrist, N, Singh, J, Lukac, J, Rovensky, J, Macejova, Z, Kalla, A, Tikly, M, Ally, Mm, Marenco, Jl, Tinture, T, Juanola, J, Alvaro Gracia JM, Rodriguez Heredia JM, Sandoval, Tp, Cheng, Tt, Luo, Sf, Lan, Jl, Osiri, M, Nilganuwong, S, Asavatanabodee, P, Nanagara, R, Louthrenoo, W, Hazleman, Bl, Jubb, R, George, E, Hakim, A, Grennan, D, Gardiner, P, Taylor, J, Mcnally, J, Hutchinson, D, Plant, M.

Publikováno v: Rheumatology (Oxford, England)
Rheumatology (Oxford, England), 49(9), 1683-1693. Oxford University Press

Objective. To evaluate the efficacy and safety of three dosing and repeat treatment regimens of rituximab (RTX) plus MTX in patients with active RA. Methods. Patients with active RA despite stable MTX (10–25 mg/week) were randomly assigned to one o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a41b182bf39f344987bb981fdd06fa7
https://hdl.handle.net/11380/1079787